Topiramate
Product Images NDC 70934-772

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 772 60 Master Bottle Label Approval Rev A 06 20)

The given text contains information about a medication with the NDC code 70934-772-60 called "Topiramate". It does not provide any further information about the medication.*

FDA Label Image

Chemical-structure (Chemical Structure)

Not available.*

FDA Label Image

Figure-1 (Figure 1)

This is a graphical representation of the cumulative rates for time to the first seizure. The X-axis represents time in days, and the Y-axis shows the cumulative rate from 0.1 to 0.5. The data is divided into two groups, one taking Topiramate 50 mg/day (N=234), and the other taking Topiramate 400 mg/day (N=238). The equal (=) sign in the graph represents the point where both groups have the same seizure rate.*

FDA Label Image

Figure-2 (Figure 2)

This is a statistical table that shows the change in average monthly migraine period rate from baseline to double-blind phase for different dosages of Topiramate and placebo. The study was conducted in two parts; Study 10 and Study 11. The table shows the number of participants (N) in each group and the corresponding p-value for statistical significance.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.